STAT July 31, 2024
Good morning, folks! The Dean of Pharmalittle University, Ed Silverman, is out on vacation. I also recently went on a mini-vacation, traveling up to a lake house for fun with friends. I’ll be writing my “What I did on summer vacation” essay later this week. But first, the news. …
A new study suggests that an older GLP-1 drug may help protect the brains of people with early Alzheimer’s disease, supporting the case for further research on this class of medications in neurological diseases, STAT reports. The Phase 2 randomized trial tested Novo Nordisk’s liraglutide, the predecessor to Ozempic and Wegovy, in patients with early Alzheimer’s disease over one year. The study did not meet the primary endpoint of change...
Today's Sponsors
Today's Sponsor